H. Grant Prentice

H. Grant Prentice's AcademicInfluence.com Rankings

H. Grant Prentice

Philosophy

#9511

World Rank

#13083

Historical Rank

Logic

#6486

World Rank

#8006

Historical Rank

philosophy Degrees

Download Badge

Philosophy

H. Grant Prentice's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Sciences Stanford University

Why Is H. Grant Prentice Influential?

(Suggest an Edit or Addition)

(See a Problem?)

H. Grant Prentice's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. (2005) (598)
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. (1996) (357)
DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS (1984) (349)
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease (2001) (279)
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation (1994) (276)
Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA (1997) (257)
Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation (1999) (242)
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. (1991) (223)
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (2000) (222)
RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI (1984) (214)
USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA (1982) (204)
Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. (2002) (195)
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease (1998) (192)
Impact of previous aspergillosis on the outcome of bone marrow transplantation. (1998) (188)
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. (1993) (184)
Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality (1999) (180)
The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties (1998) (178)
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation (1994) (171)
Second HLA-identical sibling transplants for leukemia recurrence. (1992) (169)
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature (2002) (166)
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). (1997) (165)
PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MAN (1979) (164)
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. (1998) (160)
Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation (1986) (156)
Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases (1980) (154)
TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW (1986) (151)
Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. (2001) (150)
Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. (2000) (149)
KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS (1982) (144)
Immunological analysis of the skin in graft versus host disease. (1982) (140)
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. (1983) (135)
Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. (1989) (134)
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). (1996) (130)
A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor (1982) (123)
Lipid-based amphotericin B: a review of the last 10 years of use. (2001) (123)
In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. (1989) (118)
IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS (1987) (117)
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients (2003) (117)
Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? (1988) (115)
REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIA (1980) (110)
Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy. (1989) (106)
Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. (1994) (103)
Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. (1998) (103)
Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. (1998) (95)
Temporal dynamics of CD69 expression on lymphoid cells. (1997) (95)
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. (2004) (94)
Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia. (1981) (93)
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group (1993) (93)
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. (1994) (90)
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. (1996) (89)
Fatal hepatitis B reactivation after autologous bone marrow transplantation. (1989) (89)
Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis (1999) (88)
Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response (1997) (83)
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. (1999) (82)
A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation (2006) (81)
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. (2003) (81)
A strategy for treatment of Epstein–Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells (2004) (81)
Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (1996) (80)
Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT) (1998) (78)
Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation. (1981) (76)
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. (1992) (75)
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. (2001) (75)
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia (2002) (73)
Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection (1997) (73)
ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION (1982) (73)
THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA (1981) (72)
ADOPTIVE TRANSFER OF HYPERTHYROIDISM AND AUTOIMMUNE THYROIDITIS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOID LEUKAEMIA (1990) (72)
Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus. (1997) (71)
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching (1997) (71)
Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. (1987) (69)
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. (2002) (65)
The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation (2003) (63)
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? (1992) (62)
T cell regeneration after allogeneic bone marrow transplantation. (1983) (61)
Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. (2003) (61)
The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia (1998) (60)
Donor-specific bone marrow infusion after orthotopic liver transplantation (1994) (59)
Is there a graft‐versus‐leukaemia effect in the absence of graft‐versus‐host disease in patients undergoing bone marrow transplantation for acute leukaemia? (2000) (59)
HHV‐6‐related secondary graft failure following allogeneic bone marrow transplantation (1999) (58)
Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. (1984) (57)
Non‐MHC‐restricted cytotoxic cells: their roles in the control and treatment of leukaemias (2001) (57)
T cell subpopulations, monoclonal antibodies and their therapeutic applications. (1982) (56)
Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. (1989) (55)
Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. (1988) (55)
High–dose melphalan with autologous bone marrow transplant treatment of poor prognosis tumors (1983) (54)
Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant (1997) (53)
Chaetomium pneumonia in patient with acute myeloid leukaemia. (1996) (53)
Autologous stem cell transplantation in multiple myeloma: Results of the european group for bone marrow transplantation (1995) (53)
Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants. (1987) (52)
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2. (1986) (51)
The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia (1997) (50)
Immunotherapy with interleukin 2 after ABMT in AML. (1993) (48)
SPECIFIC HYPERIMMUNE GLOBULIN FOR CYTOMEGALOVIRUS PNEUMONITIS (1985) (47)
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. (1991) (47)
Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients. (1983) (46)
A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. (1990) (46)
Expression of the human major vault protein LRP in acute myeloid leukemia. (1997) (44)
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. (1986) (43)
Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. (1991) (43)
Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. (1991) (43)
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. (2002) (42)
Granisetron in the prevention of irradiation-induced emesis. (1995) (42)
The contribution of large granular lymphocytes to B cell activation and differentiation after T-cell-depleted allogeneic bone marrow transplantation. (1986) (42)
A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction. (2000) (42)
Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase (1984) (41)
Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease. (1989) (40)
Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. (1981) (40)
Streptococcus mitis and ARDS in neutropenic patients (1991) (39)
Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts. (1987) (39)
Infection caused by Mycobacterium chelonae: a diagnostic and therapeutic problem in the neutropenic patient. (1992) (38)
Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases (1988) (38)
Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients. (1984) (38)
Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United Kingdom. (1990) (37)
Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. (1998) (37)
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft (1999) (36)
Requirements for the adoptive transfer of antibody responses to a priming antigen in man. (1990) (36)
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. (1987) (36)
B cell development and regulation after T cell-depleted marrow transplantation. (1987) (36)
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). (1994) (35)
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2000) (34)
E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia. (1994) (34)
Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. (2001) (34)
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group. (1993) (34)
Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993) (2001) (33)
Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance (2001) (33)
Immunotherapy for Hodgkin's disease. (2002) (33)
Virological and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipients (1985) (32)
Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibility. (2009) (32)
A Technique for the Concentration of Nucleated Bone Marrow Cells for in vitro Manipulation or Cryopreservation Using the IBM 2991 Blood Cell Processor (1983) (31)
5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. (1982) (31)
Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation (1987) (30)
Origin of marrow stromal cells and haemopoietic chimaerism following bone marrow transplantation determined by in situ hybridisation. (1990) (30)
Salivary amylase and pancreatic enzymes in serum after total body irradiation. (1986) (29)
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia? (2000) (29)
Sequential studies on the role of mitoxantrone in the treatment of acute leukemia. (1983) (29)
Validation and clinical application of molecular methods for the identification of molds in tissue. (2006) (29)
Oral and Intravenous Itraconazole for Systemic Fungal Infections in Neutropenic Haematological Patients: Meeting Report (1999) (28)
The pharmacokinetics of ketoconazole in severely immunocompromised patients. (1982) (28)
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients (1990) (27)
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. (1982) (27)
Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease. (1993) (27)
Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults. (1988) (26)
T-cell depletion in allogeneic bone marrow transplantation: progress and problems. (1989) (26)
Pulmonary cryptosporidiosis occurring in a bone marrow transplant patient. (1987) (25)
In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation. (1988) (25)
Respiratory infections in immunocompromised patients. (1999) (25)
Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation. (1993) (25)
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells. (1991) (25)
Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group. (1997) (25)
Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation. (1990) (23)
Standardization of the Processing of Human Bone Marrow for Allogeneic Transplantation (1986) (23)
Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. (1993) (23)
The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial. (1991) (23)
Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplant. (1995) (23)
FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission (1998) (23)
Yersinia enterocolitica transmission from a red cell unit 34 days old (1996) (23)
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus. (1990) (22)
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. (2001) (21)
Association of 17p loss with late-stage or refractory disease in hematologic malignancy. (1994) (21)
Valproic-acid-induced pancytopenia and Coombs test positivity (1991) (19)
Ingrowing toenails and cyclosporin (1993) (19)
A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia. (1983) (18)
Identification of non-naïve CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients (2003) (18)
Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment. (1999) (17)
Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia. (1993) (17)
Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation? (1992) (15)
The outcome of 267 Philadelphia positive adults in the international UKALL12/ECOG E 2993 study. Final analysis and the role of allogeneic transplant in those under 50 years. (2003) (15)
IMMUNOLOGICAL CHARACTERIZATION OF HEMOPOIETIC CELLS IN THE COMMON MARMOSET, RHESUS MONKEY, AND MAN IN SEARCH OF A MODEL FOR HUMAN MARROW TRANSPLANTATION (1981) (15)
Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis. (1989) (14)
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. (1987) (13)
Pneumonitis in bone marrow transplant recipients results from a local immune response (1990) (12)
A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients. (1988) (12)
The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations. (1983) (12)
Acute haemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation. (1991) (12)
Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements. (1993) (12)
Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1). (1992) (12)
Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). (1999) (12)
ACUTE LYMPHOBLASTIC LEUKAEMIA IN ADULTS (1986) (12)
DIFFERENTIAL RECOVERY OF PHENOTYPICALLY AND FUNCTIONALLY DISTINCT CIRCULATING ANTIGEN‐PRESENTING CELLS AFTER ALLOGENEIC MARROW TRANSPLANTATION (1988) (12)
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients. (1990) (11)
Lingual cellulitis causing upper airways obstruction in neutropenic patients. (1990) (11)
A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients. (1989) (11)
Analysis of Rejection in HLA Matched T-Depleted Bone Marrow Transplants (1985) (11)
VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. (1995) (11)
Response to "Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia". (1999) (11)
MYELODYSPLASIA AND ACUTE MYELOID LEUKAEMIA FOLLOWING BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA: SECONDARY LEUKAEMIA OR STEM‐CELL RELAPSE? (1989) (11)
Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation (2000) (10)
CD5-positive B cells after T cell depleted bone marrow transplantation. (1987) (10)
Plasma soluble interleukin 2 receptor levels in patients with malignant lymphoma are correlated with disease activity but not cellular immunosuppression. (1993) (10)
REMISSION INDUCTION IN ACUTE MYELOID LEUKAEMIA WITH ORAL ETOPOSIDE (1982) (10)
The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients (2009) (10)
Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart. (1994) (9)
Production of anti‐cytomegalovirus antibody following T‐cell depleted bone marrow transplant (1986) (9)
A515U: a prodrug of acyclovir with increased oral bioavailability. (1986) (9)
Detection of adeno-associated virus type 2 in sorted human bone marrow progenitor cells. (1997) (9)
Antiviral therapy in the immunocompromised patient. (1985) (9)
Immunocytochemical detection of breast cancer cells: a comparison of three attachment factors. (1997) (9)
Acute skin GVHD following syngeneic BMT for CLL (1998) (8)
Nucleoside incorporation into DNA and RNA in acute leukaemia: differences between the various leukaemia sub‐types (1982) (8)
Regeneration of humoral immunity to herpes simplex virus following T‐cell‐depleted allogeneic bone marrow transplantation (1987) (8)
Understanding the mechanism of cure of acute myeloid leukemia by allogeneic bone marrow transplantation: toward the application of interleukin-2 in autologous bone marrow transplantation. (1994) (8)
Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantation. (1990) (8)
Prophylactic studies against herpes infections in severely immunocompromised patients with acyclovir. (1983) (8)
Recovery of immunoglobulin isotypes following T-cell depleted allogeneic bone marrow transplantation. (1986) (8)
Humoral immune responses within the lung of bone marrow transplant recipients studied by bronchoalveolar lavage. (1988) (8)
Emergency response to nuclear and radiation accidents. (1989) (7)
Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993). (1999) (7)
Prevention of urate nephropathy in the tumour lysis syndrome. (1989) (7)
The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2. (1993) (7)
Risk factors for viral reactivation following bone marrow transplantation (2005) (7)
Do double-beta-lactam combinations prolong neutropenia in patients undergoing chemotherapy or bone marrow transplantation for hematological disease? (1989) (6)
Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration. (1991) (6)
Is the measurement of virus‐specific antibody in the lungs of transplant recipients with cytomegalovirus pneumonitis of diagnostic or prognostic value? (1988) (6)
Multidrug Resistance in Acute Leukaemia: A Comparative Study of Immunocytochemical and RNA Slot Blot Detection of P-glycoprotein Expression. (1991) (6)
Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation. (1988) (6)
XII/ECOG E2993 of more than 1500 patients from the international ALL trial: MRC UKALL Induction therapy for adults with acute lymphoblastic leukemia: results (2008) (6)
Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions. (2003) (6)
Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant. (1987) (6)
Blood product support in patients undergoing chemotherapy and autologous or allogeneic bone marrow transplantation for haematological malignancies. (2008) (5)
Infection prophylaxis in the patient with bone marrow failure. (1984) (5)
IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation. (1991) (5)
Prophylaxis and treatment of cytomegalovirus infections in the bone marrow transplant recipient. (1989) (5)
Preliminary results of a phase 2 study on a protein kinase C inhibitor (CGP 41251) in low grade lymphoproliferative disorders. (1997) (5)
Liposomal amphotericin B in neutropenic patients (1993) (5)
Absence of Bartonella-like inclusions in microangiopathy after transplantation (1998) (5)
T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead. (1989) (4)
Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function. (1991) (4)
KETOCONAZOLE AND ADRENOCORTICAL SECRETION (1985) (4)
OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation. (1982) (4)
Abnormal alveolar macrophage populations in bone marrow transplant recipients with pneumonitis. (1993) (4)
Pathogen 'shift' in febrile neutropenia. (1999) (4)
Prophylactic and empirical antifungal treatment in cancer complicated by neutropenia (1997) (4)
Purging of Bone Marrow (1987) (4)
INFECTIONS OF THE IMMUNOCOMPROMISED HOST (1993) (4)
Results of an exploratory phase ii study on a protein kinase C inhibitor in low grade lymphoproliferative disorders (1998) (3)
Clonal evolution in Ph-negative, bcr-positive chronic myeloid leukaemia before and after bone marrow transplantation. (1989) (3)
Identical-Twin Transplants for B-Cell Chronic Lymphocytic Leukemia (B-CLL). (2004) (3)
Selective removal of alloreactive lymphocytes from peripheral blood mononuclear cell preparations. (1996) (3)
The use of monoclonal antibodies in graft versus host disease prevention. (1986) (3)
Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment. (1999) (3)
Plasma albumin activates the phosphatidylinositol-3 kinase/AKT signaling pathway and protects B-CLL cells from spontaneous and chlorambacil-induced apoptosis. (2001) (3)
Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia. (1985) (3)
RP59500 (Quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium. (1998) (3)
The use of defibrotide in the management of vascular endothelial complications (VOD/HUS/TTP) of stem cell transplantation. (1999) (3)
Which febrile neutropenic patients are suitable for outpatient management (1997) (3)
Bone Marrow Transplantation in First CR of Acute Leukaemia using T-Depleted Marrow from HLA Identical Sibling Donors (1986) (3)
Host defence defects and possible approaches to their correction in the bone-marrow transplant recipient (1995) (3)
The role of mitozantrone in the treatment of acute leukaemia. (1987) (3)
RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION (1985) (2)
Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir. (1983) (2)
IgG subclasses in the lungs of patients with interstitial pneumonitis following bone marrow transplantation. (1993) (2)
Selective depletion of alloreactive lymphoctyes in HLA matched pairs (1997) (2)
Adjuvant use of GM-CSF in invasive aspergillosis. (1998) (2)
INFECTION-CONTROL ASPECTS OF BONE-MARROW TRANSPLANTATION (1994) (2)
Clinical treatment with CGP 41251 increases sensitivity of CLL cells to conventional therapy (1998) (2)
Liposomal amphotericin B for fever and neutropenia. (1999) (2)
Bone marrow transplantation in acute or chronic leukaemia. (1987) (2)
Bone marrow transplantation in the treatment of acute lymphoblastic leukaemia (1986) (2)
Activation marker expression on the peripheral blood lymphocytes of normal volunteers, recipients of Interleukin 2 and patients undergoing bone marrow transplantation (1992) (2)
A reappraisal of current approaches to the management of fungal infections in neutropenic patients. (1998) (2)
Oligoclonality: an insight into the biology of acute lymphoblastic leukaemia (2001) (2)
Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial. (2003) (2)
Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3 (2003) (1)
Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia (2004) (1)
Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation. (2000) (1)
Allogeneic bone marrow transplantation. Recent developments and the potential expansion of the donor pool. (1988) (1)
Caspase 3 activation in the absence of cytoplasmic cytochrome C elevation during apoptotic death of B-CLL cells. (1999) (1)
A role for C-ABL tyrosine kinase in p53 upregulation and apoptosis in B-CLL cells exposed to chlorambucil (2000) (1)
The presence of mild acute graft versus host disease in a T cell depleted unrelated donor transplant setting improves overall survival (2002) (1)
Current role and status of bone marrow transplantation. (1989) (1)
Future Directions in Haematology: Beyond Multiple Myeloma (2005) (1)
NK cell-mediated specific anti-leukaemic activity after autologous bone marrow transplantation for acute leukaemia. (1995) (1)
Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients. (1992) (1)
How do BMTs cure leukaemia? New directions. (1991) (1)
The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia. (1994) (1)
The role of monoclonal antibodies in the prevention of graft versus host disease (1984) (1)
Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liver. (1984) (1)
Failure of purged autologous bone marrow transplantation in high risk ALL. (1991) (1)
GM-CSF may have a role in the management of invasive aspergillosis (1A) in the neutropenic patient. (1999) (0)
HLA Down-Regulation of Cell Surface Class I Expression and Not with the CMV-Induced Function-Associated Antigen-3 (LFA-3) Induced Changes in Cell Surface Lymphocyte (CMV)-Infected Cells Correlates with Virally Natural Killer Cell Lysis of Cytomegalovirus (1998) (0)
Donor age is not a significant factor affecting overall survival in HLA matched unrelated donor stem cell transplants (2002) (0)
Transplantation study from the European Group for Blood and Marrow transplantation in multiple myeloma: a retrospective case-matched Allogeneic bone marrow transplantation versus autologous stem cell (2011) (0)
Gene expression of multidrug resistant protein (MRP) homologues in B-CLL and AML cells (2000) (0)
Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in a NOD/SCID mouse model. (1999) (0)
HLA matched T-cell depleted allogeneic BMT in the treatment of minimal residual disease (1986) (0)
Use of intravenous cidofovir for the treatment of adenovirus infection in pre/post bone marrow transplant patients (2001) (0)
Non-suppression ofcortisol secretion bylongterm treatment withketoconazole inpatients withacute leukaemia (1985) (0)
Lingual cellulitis: Authors' reply (1990) (0)
The Prophylaxis of Herpes Group Infections in Patients with Haematological Malignancy (1988) (0)
Ccurrence of autoantibodies in patients developing graft versus hostdkease after allogeneicbone marrow transplant (2000) (0)
Response to Martino and Cordonnier (2003) (0)
Rapid diagnosis of cytomegalovirus infection. (1985) (0)
PCR DETECTION OF ADENOASSOCIATED VIRUS TYPE-2 IN SORTED HUMAN BONE-MARROW CELLS (1995) (0)
Herbimycin A sensitizes Philadelphia-positive leukemia cells to apoptosis induction but does not downregulate expression of bcl-2 or bcl-X-L. (1997) (0)
Interferon-alpha treatment after autologous bone marrow transplantation and the development of in vitro anti-leukaemic immune reactivity (1996) (0)
The modulation of multidrug resistance and induction of apoptotic cell death by a PKC inhibitor CGP41251 in B-CLL cells in vitro (1997) (0)
PROMOTER COMPETITION IN A RETROVIRAL CONSTRUCT CONTAINING A DOMINANT SELECTIVE GENE IS NOT REVERSIBLE FOLLOWING WITHDRAWAL OF SELECTIVE PRESSURE (1995) (0)
CDSαon human natural killer cells may act as a costimulatory molecule (2000) (0)
Antimicrobial prophylaxis and treatment in the patient with bone marrow failure (1992) (0)
Graft versus host disease in matched T cell depleted unrelated donor haematopoietic stem cell transplants. (2006) (0)
Inhibitor of apoptosis XIAP expression in cells from B-CLL patients treated with DNA damaging agents. (2001) (0)
Activation of caspase 8 in the absence of FAS ligation in the killing of B-CLL cells by cytotoxic drugs and radiation (2000) (0)
The GvH reaction: The 'cytokine storm' and its effect on lymphocyte alloreactive responses. (1999) (0)
Detection and characterisation of tumour cells in the peripheral blood of patients with primary breast cancer. (1997) (0)
What is the risk of transfusing micro-organisms during stem cell transplantation? (2000) (0)
Graft-versus-leukaemia immunity can be detected in patients in remission but is absent prior to and during haematological relapse. (1997) (0)
Salivary Amylase andPancreatic Enzymes inSerumafterTotalBody Irradiation (1986) (0)
CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION (1987) (0)
Factors implicated in disease relapse following volunteer donor unrelated stem cell transplantation (2002) (0)
The protein tyrosine kinase inhibitor herbimycin A augments cytotoxic drug-induced apoptosis in B-CLL cells cultured with interleukln-4 or autologous plasma. (1999) (0)
Ultrasensitive immunocytochemical and fluorescent detection and characterisation of circulating and micrometastatic tumour cells in patients with breast cancer. (1999) (0)
DoDouble-1-Lactam Combinations Prolong Neutropenia inPatients Undergoing Chemotherapy orBoneMarrowTransplantation for Hematological Disease? (1989) (0)
Recent Advances in the Treatment of Multiple Myeloma: European Expert Meeting: Proceedings (2005) (0)
HLA-DPB1 plays a role in the outcome of unrelated stem cell transplants in pairs completely matched at the other five transplantation loci (2002) (0)
The modulation of multidrug resistance by CGP41251 in B-chronic lymphocytic leukaemia cells in vitro. (1997) (0)
Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL (2002) (0)
Expression of the multidrug resistance protein gene homologues in B-CLL and AML cells. (1999) (0)
LACK OF INCREASED INCIDENCE OF SYSTEMIC FUNGAL-INFECTIONS AFTER LYMPHOCYTE-T-DEPLETED ALLOGENEIC BMT (1988) (0)
Understanding the Mechanisms of Cure in Acute Myeloblastic Leukaemia: Towards a Modern Immunotherapy (1992) (0)
Expression of the mutli-drug resistance associated protein (MRP) in haematological malignancy (1994) (0)
The differential effects of cytokines on the expression of major histocompatibility antigens and adhesion molecules on lymphocytes. (1998) (0)
Cytotoxic effects of deoxyadenosine and deoxycoformycin in human lymphoid cells (1982) (0)
Aminoglycoside toxicity. (1985) (0)
Functional dichotomy between CD69 + ve NK cell subsets isolated from adult peripheral blood and cord blood (1997) (0)
A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. (2002) (0)
Monoclonal Antibodies in Bone Marrow Transplantation (1982) (0)
Significance of quantitative-competitive PCR for human herpes virus-6, human herpes virus-7 and cytomegalovirus following bone marrow transplantation. (1998) (0)
Immune reconstitution after T cell depleted autologous stem cell transplantation for the treatment of systemic sclerosis (1997) (0)
Liposomal amphotericin B and erythrocyte echinocytosis. (1991) (0)
CD8 alpha on human natural killer cells may act as a costimulatory molecule. (2000) (0)
Mild acute graft versus host disease improves overall survival in well matched T cell depleted unrelated donor transplants (2002) (0)
T cell depletion in allogeneic bone marrow transplantation. (1987) (0)
Enchancement of the TNF-related apoptis-inducing ligand (TRAIL) mediated apoptosis of AML cells by cytotoxic agents (2000) (0)
Main Session III (2002) (0)
Adeno-associated virus mediated transfer of interleukin-12 to human CD34+ bone marrow cells and leukaemic blasts. (1995) (0)
The putative role of Fas and caspase 8 in the killing of B-CLL cells by cytotoxic drugs and radiation. (1999) (0)
Disease relapse following volunteer donor haematopoietic stem cell transplantation. (2006) (0)
Impact of azole prophylaxis on candida colonisation and infections in neutropenia (2000) (0)
Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. (2002) (0)
What is the risk of infection in patients undergoing peripheral blood stem cell transplantation (1996) (0)
Pre-clinical evaluation of candidate antibodies for targeted radiotherapy for patients with multiple myeloma (2000) (0)
Leukaemia (1983) (0)
Expression of the costimulatory molecules CD80 and CD86 on myeloid leukaemic blasts (1996) (0)
Quantitation of the Multi-drug Resistant MDR-1 transcript in acute leukaemia by non-isotopic quantitative cDNA polymerase chain reaction. (1994) (0)
Antithrombin III in the diagnosis of infection in febrile neutropenic patients (1988) (0)
The Cellular Basis of the Immune Response (1977) (0)
CMV-induced augmentation of GVL effect may be mediated by cytokines. (1991) (0)
The Addition of Granulocyte-Macrophage Colony-Stimulating Factor to Normal Bone Marrow Enhances Cell Cycle and Clonogenicity Irrespective of Cryopreservation (1992) (0)
The influence of interleukin-2 (IL-2), IL-7 and IL-15 on the development of natural killer cells. (1998) (0)
Purging in autologous bone marrow transplantation (ABMT): Importance of antigen density on leukaemia blasts for the efficiency of complement-mediated cytolysis (1986) (0)
The application of flow cytometry for the detection and investigation of leukaemia-specific immunity. (1996) (0)
The prophylaxis of infection in patients with malignant disease (1985) (0)
Hepatocyte progenitor cells in massive hepatic necrosis (2003) (0)
Adeno-associated virus mediated gene transfer of B7.1 to CD34+ bone marrow cells and acute myeloid leukaemia blasts. (1995) (0)
Surgical Infection in Critical Care Medicine (Clinics in Critical Care Medicine series). Jonathan L. Meakins. Churchill Livingstone, 1985. No. of pages: 1-342 including Index. Price: £22.00. ISBN 0 443 02971 7 (1986) (0)
The detection and genetic analysis of low frequency epithelial tumour cells in patients with breast cancer (1996) (0)
The AKT protein kinase mediates plasma-induced survival of B-CLL cells (2000) (0)
MONOCLONAL ANTIBODIES AND CANCER (1981) (0)
Targeted radiotherapy for patients with multiple myeloma: Results of pre-clinical evaluation of candidate antibodies (1999) (0)
lgG subclasses in the lungs of patients with interstitial pneumonitis following bone marrow transplantation (2012) (0)
The genetic factors which affect the outcome of unrelated bone marrow transplantation (2000) (0)
Canlungfunction measurementsbeusedto predict whichpatients will beatrisk ofdeveloping interstitial pneumonitisafter bonemarrow transplantation (1992) (0)
Phase I clinical trial of recombinant IL2 following chemoradiotherapy (1989) (0)
New developments in post-induction therapy for acute myeloblastic leukaemia. (1989) (0)
175Upregulation of the expression of molecules involved in allorecognition: Implications for potentiating the mixed lymphocyte reaction prior to selective alloreactive T cell depletion (2003) (0)
Expression of breast cancer resistance protein (BCRP) in malignant cells from patients with B-chronic lymphocytic leukaemia (B-CLL) and acute lymphoblastic leukemia (ALL). (2000) (0)
Molecular detection of minimal residual disease (MRD) in adult and childhood all reveals differences in treatment response (1995) (0)
A phase Iclinical trial ofrecombinant interleukin 2following highdose chemo-radiotherapy forhaematological malignancy: applicability tothe elimination ofminimal residual disease (1989) (0)
[Therapeutic advances in bone marrow transplantation]. (1987) (0)
THE DETECTION OF REARRANGED TCR-GAMMA GENES IN T-CELL ALL BY A RADIOLABELED POLYMERASE CHAIN-REACTION ASSAY (1993) (0)
Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function (1991) (0)
Alloantigen-specific T cell depletion: From the bench to the bedside via a murine model (2000) (0)
Acute myleoid leukemia cells induce T cell but not NK cell unresponsiveness - Implications for the adoptive immunotherapy of leukemia. (2000) (0)
FLOW-CYTOMETRY OF RETICULOCYTES TO DEMONSTRATE ENGRAFTMENT REJECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) (1993) (0)
Measurement of autologous immunity to leukaemia can predict maintenance of complete remission at two years. (1999) (0)
A FLOW CYTOMETRIC METHOD FOR STUDYING NK CELL CONJUGATE FORMATION POST BMT (1995) (0)
Production de vecteur-aav (virus adeno-associe) (1999) (0)
Increases in cytoplasmic cytochrome c is not a rate-limiting step in the induction of apoptosis of B-CLL cells (2000) (0)
Differential expression of the alternatively spliced STAT-1 alpha and beta mRNA and its products in B-CLL and tonsillar B-cells. (1999) (0)
AML-reactive autologous NK cells predict patient survival and can prevent leukaemia outgrowth in an animal model. (1999) (0)
Hypoparathyroidism and Hypocalcaemia during Therapy for Acute Leukemia (1981) (0)
Inhibition of P-gp activity in aml patients treated with zosuquidar trihydrochloride (LY335979): in vitro data from a phase 1 trial (2003) (0)
Combined foscarnet and ganciclovir at half doses for the pre-emptive treatment of CMV infection: A pilot study. (1999) (0)
Establishment of the NOD/SCID mouse as a model for allogeneic GvHD. (1999) (0)
The importance of patient and donor CMV status in unrelated stem cell transplantation (2002) (0)

This paper list is powered by the following services:

H. Grant Prentice's Academic­Influence.com Rankings

H. Grant Prentice's Degrees

Why Is H. Grant Prentice Influential?

H. Grant Prentice's Published Works

Published Works

H. Grant Prentice's AcademicInfluence.com Rankings